Emerging products, cultivation techniques, and synthetic cannabinoid breakthroughs.
For two decades, commercial use of raw acidic cannabinoids sat inside a corporate patent claim. That patent has now expired. But the cancer‑treatment patent built on top of it remains in force, shaping who gets to turn a plant into medicine — and who gets left outside the system.
Crystal Ball Predictions with Bill & Emjay cuts through the smoke and mirrors to reveal how the 2026 patent expiry, Schedule III reform, and shifting market forces are about to reshape cannabinoid medicine. Follow the money, see the signals, and watch the future unfold.
Real Guidelines: We are not just growing a plant. We are cultivating our tactics, our messenger network, and our reach—carefully, strategically, and rooted in the fertile soil of a just cause. We use the tools of the present to dismantle the lies of the past, so we can build a future that honours the heart of our movement.
